BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2575713)

  • 21. [Molecular biology in cerebral gliomas: recent advances].
    Hoang-Xuan K; Li YJ; Hamelin R; Delattre O
    Rev Neurol (Paris); 1995 Nov; 151(11):608-18. PubMed ID: 8745624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phacomatosis and genetically determined tumors: the transition from childhood to adulthood].
    de Ribaupierre S; Vernet O; Vinchon M; Rilliet B
    Neurochirurgie; 2008 Oct; 54(5):642-53. PubMed ID: 18752812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenes and anti-oncogenes in human central nervous system tumors.
    Batra SK; Rasheed BK; Bigner SH; Bigner DD
    Lab Invest; 1994 Nov; 71(5):621-37. PubMed ID: 7967518
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors].
    Müller H; Scott RJ
    Schweiz Med Wochenschr; 1995 Jul; 125(30):1445-54. PubMed ID: 7676234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
    Nabors LB; Gillespie GY; Harkins L; King PH
    Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microarray analysis of differentially expressed genes of primary tumors in the canine central nervous system.
    Thomson SA; Kennerly E; Olby N; Mickelson JR; Hoffmann DE; Dickinson PJ; Gibson G; Breen M
    Vet Pathol; 2005 Sep; 42(5):550-8. PubMed ID: 16145201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression as exemplified by human astrocytic tumors.
    Collins VP
    Semin Cancer Biol; 1999 Aug; 9(4):267-76. PubMed ID: 10448114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The history of von Hippel-Lindau disease.
    Molino D; Sepe J; Anastasio P; De Santo NG
    J Nephrol; 2006; 19 Suppl 10():S119-23. PubMed ID: 16874724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Hippel-Lindau disease: a model system for the isolation of "tumor suppressor" genes associated with the primary genetic mechanisms of cancer.
    Seizinger BR
    Adv Nephrol Necker Hosp; 1994; 23():29-42. PubMed ID: 8154360
    [No Abstract]   [Full Text] [Related]  

  • 31. [Meningiomas: anatomical pathology and molecular biology].
    Bekiashev AKh; Korshunov AG; Cherekaev VA
    Arkh Patol; 2007; 69(5):48-54. PubMed ID: 18074823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetic aspects of glial tumour evolution.
    James CD; Mikkelsen T; Cavenee WK; Collins VP
    Cancer Surv; 1990; 9(4):631-44. PubMed ID: 1983210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biology of brain tumors.
    McDonald JD; Dohrmann GJ
    Neurosurgery; 1988 Nov; 23(5):537-44. PubMed ID: 3059215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathogenesis of skull base tumors.
    Patel NP; Mhatre AN; Lalwani AK
    Otol Neurotol; 2004 Jul; 25(4):636-43. PubMed ID: 15241249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fundamental mechanisms of tumorigenesis in the human nervous system: isolation and characterization of genes associated with hereditary forms of cancer.
    Seizinger BR
    Clin Chem; 1989 Jul; 35(7 Suppl):B25-7. PubMed ID: 2568194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressor genes: the puzzle and the promise.
    Sager R
    Science; 1989 Dec; 246(4936):1406-12. PubMed ID: 2574499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular probes in neuro-oncology: a review.
    Rutka JT; Trent JM; Rosenblum ML
    Cancer Invest; 1990; 8(3-4):425-38. PubMed ID: 2169969
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular pathogenesis of astrocytoma and glioblastoma multiforme.
    Van de Kelft E
    Acta Neurochir (Wien); 1997; 139(7):589-99. PubMed ID: 9265950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppressor genes and inherited predisposition to malignancy.
    Skuse GR; Rowley PT
    Semin Oncol; 1989 Apr; 16(2):128-37. PubMed ID: 2565603
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and molecular neurogenetics in neurosurgery.
    Harding AE
    Adv Tech Stand Neurosurg; 1993; 20():81-104. PubMed ID: 8397537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.